Thanks to the partnership with Credimi, Banca Sella will be able to guarantee its customers, who carry out economic activities within the perimeter provided for by the so-called Liquidity Decree, even faster times for the management of the loan applications provided for by the Decree. That offers the possibility to apply for a loan up to $27,300 (€25,000) or in any case not exceeding 25% of 2019 revenues, with the coverage of the guarantee fund of 100%.
If you want to find more about the partnership between Banca Sella and Credimi and to read the latest financial news, download for free our companion app Born2Invest.
Credimi’s system will automatically process loans requests
Individual companies that are clients of Banca Sella will be able to apply for this loan directly from the bank’s internet banking, without going through the branch and without submitting any form or paperwork. The application will be taken care of by Credimi’s systems, which will process the request almost automatically, interfacing digitally with the central guarantee fund, without any burden for the customer, excluding the signatures (all digital) required by law.
The answer will arrive in a few days and the disbursement will take place immediately after the issue of the guarantee.
“The agreement with Credimi is part of the initiatives that our Bank has put in place in recent weeks to support the economy and customers in difficulty due to the COVID-19 emergency. In particular, with respect to the loan applications provided for in the Liquidity Decree, we have organized ourselves to guarantee our customers rapid handling of requests both internally and through the strategic partnership with Credimi. This organization allows us to respond to customers’ needs and process requests in the shortest possible time,” said Andrea Massitti, Head of Corporate and Small Business at Banca Sella.
“The operation signed by Credimi and Banca Sella is a virtuous example of how the various financial players can work together to improve this country. An effective collaboration that frees up liquidity, in the most effective and fastest way possible, for that group of smaller companies, with fewer resources available and therefore more affected by this health and economic emergency,” stressed Ignazio Rocco di Torrepadula, founder and CEO of Credimi.
Credimi also entered into a partnership with Generali
At the beginning of April, Credimi structured the securitization Italianonsiferma, with Generali, through its Extraordinary International Fund launched to face the coronavirus emergency. The fund will be anchor investor of the junior tranche, with a share of $11 million (€10 million) on a final target of $109 (€100 million).
In early 2020, Credimi launched Credimi Capitale Umano, a financing formula to support the growth of SMEs and employment, launched in partnership with Openjobmetis, the employment agency listed on the Star segment of Borsa Italiana. Last March, on the other hand, the fintech company launched Credimi Start, a new financing product dedicated to very small companies and startups, to help them overcome the difficult market situation created by the coronavirus pandemic.
Founded by Ignazio Rocco di Torrepadula, former senior partner of BCG, together with a team of young people with technological and financial experience, Credimi is a fintech startup that has so far raised over $19.7 million (€18 million) of capital from investors in two different rounds. The first $8.7 million (€8 million) in two successive rounds closed in February 2016 by well-known entrepreneurs and finance professionals, and the other $11 million (€10 million) in September 2018, led by UV2 (United Ventures sgr) and Vertis Venture 2 Scaleup (Vertis sgr).
DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published in BeBeez, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
Five Impact Investment Projects around the World
Impact investing gives investors the opportunity not only to earn a return on their money but also to have a...
HoMu Health Ventures Launches in Reproductive Medicine
HoMu Health Ventures has its own capital to financially support emerging companies in their pre-seed and seed phase. In this...
Transitory Inflation Debate
The US economy is about to go over a massive fiscal cliff; and the monetary cliff is just as deep....
Due to Demand Concerns, the Rice Prices were Lower Last Week
Rice prices were lower for the week in good volume trading on demand concerns. It looked like speculators were the...
Genomcore Finalizes its Entry into the United Kingdom after Increasing its Turnover by 73% in 2021
Genomcore has recently entered the market in the United Kingdom. In 2020, the company had a turnover of $912,000 (€750,000),...
Featured7 days ago
Crowdfunding for the Creation of a Legal Defense Fund for Wind Power Projects Completed
Crypto6 days ago
Stablecoins: The New Kid On The Crypto Block
Africa7 days ago
The Valorization of Technologies, Inventions, and Innovations in Burkina Faso
Business7 days ago
Painting Startups By Numbers Part 1: An Overview Of Metrics